1.
Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD).
2.
3.
4.
5.
6.
7.
DOP069 Natural history of dysplasia and colorectal cancer in IBD patients in Belgium tertiary care centers
Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.